ASC30_39 FDC

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameASC30_39 FDC
Drug Alias NameASC-39/ASC-30ASC30_39 FDC
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsYes ASC-39ASC-30
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAscletis Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAscletis Pharma Inc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A